Diabetes mellitus as a risk factor for gastrointestinal cancers among postmenopausal women

Cancer Causes and Control

Volumn 24, Issue 3, 2013, Pages 577-585

  Luo, Juhua ^a   Chlebowski, Rowan ^b   Liu, Simin ^c   McGlynn, Katherine A ^d   Parekh, Niyati ^e   White, Donna L ^f   Margolis, Karen L ^g  

^a WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HARBOR UCLA MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

^e NEW YORK UNIVERSITY   (United States)

^f BAYLOR COLLEGE OF MEDICINE   (United States)

^g HEALTHPARTNERS RESEARCH FOUNDATION   (United States)

Author keywords

Biliary; Colon and rectal; Diabetes; Esophagus; Gastrointestinal cancers; Liver; Pancreas; Stomach

Indexed keywords

ADULT; AGED; ARTICLE; BILIARY TRACT CANCER; CANCER RISK; COLON CANCER; DIGESTIVE SYSTEM CANCER; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; ESOPHAGUS CANCER; FEMALE; HUMAN; LIVER CANCER; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS CANCER; PATIENT ASSESSMENT; POSTMENOPAUSE; PRIORITY JOURNAL; RECTUM CANCER; RISK ASSESSMENT; STOMACH CANCER; WOMEN'S HEALTH;

AGED; DIABETES MELLITUS, TYPE 2; FEMALE; GASTROINTESTINAL NEOPLASMS; HUMANS; INCIDENCE; MIDDLE AGED; POSTMENOPAUSE; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SEER PROGRAM; UNITED STATES;

EID: 84878822962     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-012-9996-8     Document Type: Article

References (38)

1. Stovring H, Andersen M, Beck-Nielsen H, Green A, Vach W (2003) Rising prevalence of diabetes: evidence from a Danish pharmaco-epidemiological database. Lancet 362:537-538
2. Giovannucci E, Harlan DM, Archer MC et al (2010) Diabetes and cancer: a consensus report. Diabetes Care 33:1674-1685
3. Seshasai SR, Kaptoge S, Thompson A, et al. Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med 364:829-841
4. Pollak M (2008) Insulin and insulin-like growth factor signalling in neoplasia. Nat Rev Cancer 8:915-928
5. Larsson SC, Orsini N, Wolk A (2005) Diabetes mellitus and risk of colorectal cancer: a meta-analysis. J Natl Cancer Inst 97:1679-1687
6. Berster JM, Goke B (2008) Type 2 diabetes mellitus as risk factor for colorectal cancer. Arch Physiol Biochem 114:84-98
7. Huxley R, Ansary-Moghaddam A, Berrington de Gonzalez A, Barzi F, Woodward M (2005) Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies. Br J Cancer 92:2076-2083
8. El-Serag HB, Hampel H, Javadi F (2006) The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence. Clin Gastroenterol Hepatol 4:369-380
9. Hassan MM, Curley SA, Li D, et al. Association of diabetes duration and diabetes treatment with the risk of hepatocellular carcinoma. Cancer 116:1938-1946
10. Grote VA, Becker S, Kaaks R (2011) Diabetes mellitus type 2 - an independent risk factor for cancer? Exp Clin Endocrinol Diabetes 118:4-8
11. Adami HO, Chow WH, Nyren O et al (1996) Excess risk of primary liver cancer in patients with diabetes mellitus. J Natl Cancer Inst 88:1472-1477
12. Jamal MM, Yoon EJ, Vega KJ, Hashemzadeh M, Chang KJ (2009) Diabetes mellitus as a risk factor for gastrointestinal cancer among American veterans. World J Gastroentrol 15:5274-5278
13. Atchison EA, Gridley G, Carreon JD, Leitzmann MF, McGlynn KA (2010) Risk of cancer in a large cohort of U.S. veterans with diabetes. Int J Cancer 128:635-643
14. Inoue M, Iwasaki M, Otani T, Sasazuki S, Noda M, Tsugane S (2006) Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan. Arch Intern Med 166:1871-1877
15. La Vecchia C, Negri E, Decarli A, Franceschi S (1997) Diabetes mellitus and the risk of primary liver cancer. Int J Cancer 73:204-207
16. La Vecchia C, Negri E, Decarli A, Franceschi S (1998) Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group. Control Clin Trials 19:61-109
17. Hays J, Hunt JR, Hubbell FA et al (2003) The Women's Health Initiative recruitment methods and results. Ann Epidemiol 13:S18-S77
18. Jackson RD, LaCroix AZ, Cauley JA, McGowan J (2003) The Women's Health Initiative calcium-vitamin D trial: overview and baseline characteristics of participants. Ann Epidemiol 13:S98-S106
19. Langer RD, White E, Lewis CE, Kotchen JM, Hendrix SL, Trevisan M (2003) The Women's Health Initiative Observational Study: baseline characteristics of participants and reliability of baseline measures. Ann Epidemiol 13:S107-S121
20. Ritenbaugh C, Patterson RE, Chlebowski RT et al (2003) The Women's Health Initiative Dietary Modification trial: overview and baseline characteristics of participants. Ann Epidemiol 13:S87-S97
21. Stefanick ML, Cochrane BB, Hsia J, Barad DH, Liu JH, Johnson SR (2003) The Women's Health Initiative postmenopausal hormone trials: overview and baseline characteristics of participants. Ann Epidemiol 13:S78-S86
22. Margolis KL, Lihong Q, Brzyski R et al (2008) Validity of diabetes self-reports in the Women's Health Initiative: comparison with medication inventories and fasting glucose measurements. Clin Trials 5:240-247
23. Jackson JM, DeFor TA, Crain AL, et al. Validity of diabetes self-reports in the Women's Health Initiative. J Clin Epi (in press)
24. Hess KR (1995) Graphical methods for assessing violations of the proportional hazards assumption in cox regression. Stat Med 14:1707-1723
25. Pisani P (2008) Hyper-insulinaemia and cancer, meta-analyses of epidemiological studies. Arch Physiol Biochem 114:63-70
26. Walker A (1991) Observation and inference. An introduction to the methods of epidemiology. Epidemiology Resources Inc., USA
27. Petrides AS, Vogt C, Schulze-Berge D, Matthews D, Strohmeyer G (1994) Pathogenesis of glucose intolerance and diabetes mellitus in cirrhosis. Hepatology 19:616-627
28. Angulo P, Keach JC, Batts KP, Lindor KD (1999) Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology 30:1356-1362
29. Wanless IR, Lentz JS (1990) Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors. Hepatology 12:1106-1110
30. Zen Y, Katayanagi K, Tsuneyama K, Harada K, Araki I, Nakanuma Y (2001) Hepatocellular carcinoma arising in non-alcoholic steatohepatitis. Pathol Int 51:127-131
31. Davila JA (2010) Diabetes and hepatocellular carcinoma: what role does diabetes have in the presence of other known risk factors? Am J Gastroenterol 105:632-634
32. Sanyal A, Poklepovic A, Moyneur E, Barghout V Population-based risk factors and resource utilization for HCC: US perspective. Curr Med Res Opin 26:2183-2191
33. Gapstur SM, Gann PH, Lowe W, Liu K, Colangelo L, Dyer A (2000) Abnormal glucose metabolism and pancreatic cancer mortality. Jama-J Am Med Assoc 283:2552-2558
34. Wideroff L, Gridley G, Mellemkjaer L et al (1997) Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark. J Natl Cancer Inst 89:1360-1365
35. Coughlin SS, Calle EE, Teras LR, Petrelli J, Thun MJ (2004) Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults. Am J Epidemiol 159:1160-1167
36. Currie CJ, Poole CD, Gale EA (2009) The influence of glucose-lowering therapies on cancer risk in type 2 diabetes. Diabetologia 52:1766-1777
37. Libby G, Donnelly LA, Donnan PT, Alessi DR, Morris AD, Evans JM (2009) New users of metformin are at low risk of incident cancer: a cohort study among people with type 2 diabetes. Diabetes Care 32:1620-1625
38. Bowker SL, Majumdar SR, Veugelers P, Johnson JA (2006) Increased cancer-related mortality for patients with type 2 diabetes who use sulforrylureas or insulin. Diabetes Care 29:254-258